Your browser doesn't support javascript.
loading
Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma.
Shin, Junghoon; Lee, Ji Yun; Lee, Gyeong-Won; Kim, Won Seog; Park, Yong; Do, Young Rok; Kim, Dae Sik; Kim, Ki Hwan; Choi, Yoon Seok; Byun, Ja Min; Hong, Junshik; Kim, Inho; Yoon, Sung-Soo; Koh, Youngil.
Afiliação
  • Shin J; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Lee JY; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Seoul, Korea.
  • Lee GW; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Kim WS; Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea.
  • Park Y; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Seoul, Korea.
  • Do YR; Division of Hematology-Oncology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
  • Kim DS; Department of Hematology-Oncology, Keimyung University School of Medicine, Daegu, Korea.
  • Kim KH; Division of Hematology-Oncology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
  • Choi YS; Division of Hematology and Medical Oncology, Department of Internal Medicine, Boramae Medical Center, Seoul, Korea.
  • Byun JM; Division of Hematology-Oncology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea.
  • Hong J; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Kim I; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Yoon SS; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Koh Y; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Br J Haematol ; 202(6): e54-e57, 2023 09.
Article em En | MEDLINE | ID: mdl-37408333
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto Limite: Adult / Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto Limite: Adult / Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article